A Mouse Study Found Persistent Electrical Hyperexcitability Despite Tolerance to THC Motor Effects

A 1986 mouse study reported prolonged susceptibility to electrically induced convulsions after THC, while repeated treatment produced tolerance to motor toxicity but not that excitability endpoint. Adaptation differed between visible movement effects and a later electrical challenge.

The exposure was a high-dose injected protocol

The experiment examined a wide high-dose THC range and measured electrical convulsion susceptibility after exposure. The response peaked later than administration and persisted across the reported time course. It should not be equated with a count of spontaneous seizures in ordinary cannabis users.

Repeated exposure did not eliminate the later response

Motor-toxic effects became tolerant rapidly, but no tolerance to rebound hyperexcitability was detected after the repeated regimen. The investigators also reported changes in electrical kindling and a later phenytoin challenge. These findings concern particular laboratory procedures rather than every aspect of seizure control.

Functional significance was model-specific

The authors interpreted the pattern as a prolonged increase in central excitability. That conclusion does not establish a comparable duration or risk in people, particularly given species and dose differences. The experiment did not test purified CBD or a clinical epilepsy treatment protocol.

The study cautions against using tolerance to an obvious acute behavior as proof that delayed responses have disappeared. It does not provide a human seizure-risk calculator or justify changes to prescribed therapy. The electrical endpoint, challenge timing and harmful exposure conditions must remain explicit.

Related: interpreting cannabis tolerance claims.

Research cited

Karler R; Calder LD; Turkanis SA. Prolonged CNS hyperexcitability in mice after a single exposure to delta-9-tetrahydrocannabinol. Neuropharmacology (1986). doi:10.1016/0028-3908(86)90240-6. Findings discussed from the study abstract.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

A 2026 Cannabis Review Explains Why Potency, Placebo Response and Sedation Need Separate Measures

A 2026 narrative review argues that product potency is not the same as delivered THC dose and that placebo responses remain important among experienced users. Its laboratory framework also distinguishes reduced drug reinforcement from nonspecific sedation. Users can change how they inhale The review notes that participants alter inhalation patterns…

Spread the love

Read Article: A 2026 Cannabis Review Explains Why Potency, Placebo Response and Sedation Need Separate Measures

THC Antinociception Persisted Without the Same Dynorphin Signal in Tolerant Rats

A 1999 rat study found that tolerance weakened THC-related modulation of spinal dynorphin, while antinociception could still occur without the same elevated dynorphin measure. The role of a downstream signal changed with dose and adaptive state. The experiment examined spinal responses The work followed earlier findings linking acute intrathecal THC…

Spread the love

Read Article: THC Antinociception Persisted Without the Same Dynorphin Signal in Tolerant Rats

A Passiflora-Derived Fraction Reduced THC Withdrawal Signs in a Mouse Model

A 2002 mouse experiment reported fewer antagonist-precipitated withdrawal signs with a Passiflora-derived benzoflavone fraction. The finding concerns a defined experimental preparation and animal model, not a demonstrated treatment for cannabis-use disorder in people. Concurrent and acute interventions were tested Mice received repeated oral THC with or without the fraction. A…

Spread the love

Read Article: A Passiflora-Derived Fraction Reduced THC Withdrawal Signs in a Mouse Model

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us